Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Socinski

Showing results (61-70 of 279) with videos related to

Pageof 28
Sort By:
JCO Precision Oncology|May 26, 2021
<i>MET</i> Exon 14 Skipping Mutations in Non-Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing ConsiderationsMark A Socinski, Nathan A Pennell, Kurtis D Davies
Seminars in Oncology|April 9, 2005
The evolving role of pemetrexed (Alimta) in lung cancerMark A Socinski, Thomas E Stinchcombe, D Neil Hayes
Clinical Lung Cancer|January 15, 2004
Gemcitabine-based combinations as preoperative therapy in resectable non-small-cell lung cancerMark A Socinski, M Patricia Rivera, Frank C Detterbeck
Oncology (Williston Park, N.Y.)|April 17, 2010
The many controversies of stage IIIA/IIIB lung cancerMark A Socinski, Nirmal K Veeramachaneni, Benjamin E Haithcock
Current Oncology Reports|April 27, 2012
Management of non-small cell lung cancer with oligometastasisLiza C Villaruz, Gregory J Kubicek, Mark A Socinski
Clinical Lung Cancer|November 11, 2009
Treatment of surgically resectable non-small-cell lung cancer in elderly patientsBenjamin E Haithcock, Thomas E Stinchcombe, Mark A Socinski
Chinese Clinical Oncology|November 21, 2022
GEMSTONE-302: "If you keep doing the same thing you get the same result"Mengni Guo, Jieying Liu, Tarek Mekhail, et al.
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Duration of therapy in advanced, metastatic non-small-cell lung cancerMark A Socinski, Maria Q Baggstrom, Thomas A Hensing
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Response to Letter to the EditorMakoto Nishio, Diana Mendus, Lijia Wang, et al.
Clinical Lung Cancer|June 13, 2006
Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional statusThomas E Stinchcombe, Carrie B Lee, Mark A Socinski
Pageof 28

Showing results (61-70 of 279) with videos related to

Sort By:
Pageof 28
JCO Precision Oncology|May 26, 2021
<i>MET</i> Exon 14 Skipping Mutations in Non-Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing ConsiderationsMark A Socinski, Nathan A Pennell, Kurtis D Davies
Seminars in Oncology|April 9, 2005
The evolving role of pemetrexed (Alimta) in lung cancerMark A Socinski, Thomas E Stinchcombe, D Neil Hayes
Clinical Lung Cancer|January 15, 2004
Gemcitabine-based combinations as preoperative therapy in resectable non-small-cell lung cancerMark A Socinski, M Patricia Rivera, Frank C Detterbeck
Oncology (Williston Park, N.Y.)|April 17, 2010
The many controversies of stage IIIA/IIIB lung cancerMark A Socinski, Nirmal K Veeramachaneni, Benjamin E Haithcock
Current Oncology Reports|April 27, 2012
Management of non-small cell lung cancer with oligometastasisLiza C Villaruz, Gregory J Kubicek, Mark A Socinski
Clinical Lung Cancer|November 11, 2009
Treatment of surgically resectable non-small-cell lung cancer in elderly patientsBenjamin E Haithcock, Thomas E Stinchcombe, Mark A Socinski
Chinese Clinical Oncology|November 21, 2022
GEMSTONE-302: "If you keep doing the same thing you get the same result"Mengni Guo, Jieying Liu, Tarek Mekhail, et al.
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Duration of therapy in advanced, metastatic non-small-cell lung cancerMark A Socinski, Maria Q Baggstrom, Thomas A Hensing
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Response to Letter to the EditorMakoto Nishio, Diana Mendus, Lijia Wang, et al.
Clinical Lung Cancer|June 13, 2006
Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional statusThomas E Stinchcombe, Carrie B Lee, Mark A Socinski
Pageof 28